Statistics for Economic Burden Of Short-Acting Beta-2 Agonist (Saba) Overuse Among Asthma Patients In Türkiye: A Cost Analysis With Respect To The Updated Gina Treatment Recommendations

Total visits

views
Economic Burden Of Short-Acting Beta-2 Agonist (Saba) Overuse Among Asthma Patients In Türkiye: A Cost Analysis With Respect To The Updated Gina Treatment Recommendations 0

Total visits per month

views
August 2025 0
September 2025 0
October 2025 0
November 2025 0
December 2025 0
January 2026 0
February 2026 0

File Visits

views
s12890-024-03327-9.pdf 1